The U.S. Food and Drug Administration has approved a new prescription drug, Toviaz (fesoterodine fumarate), to treat overactive bladder in adults. Overactive bladder (OAB) in adults is characterized by urinary frequency and sudden urinary incontinence, Toviaz relaxes the bladders smooth muscle tissue reducing the urge to urinate.

George Benson, MD, deputy director of the Division of Reproductive and Urologic Products at the FDA's Center for Drug Evaluation and Research said, "Patients who suffer from overactive bladder face quality of life issues that can hamper their ability to enjoy life to its fullest. This new drug will provide an additional treatment option to help them manage problems with an overactive bladder."

A medical check-up camp titled “The Dental Specialist”, will be organized on November 2 (Sunday) from 10 am to 5 pm at the Indian Medical Association (IMA) hall at Shivabhagh in Mangalore.

While talking with media persons, Dr Chetan Hegde said, “As soon as the camp will be concluded, a dental education camp will also be organized by us on the same day.”

A new Australian study has disclosed that gym exercises, yoga head stands, swimming, or playing a musical instrument may lead to eye diseases like glaucoma and short-sightedness.

Professor Charles McMonnies, from the University of New South Wales School of Optometry and Vision Science, said, “Yoga head stands, weightlifting, sleeping face down, playing instruments like the trumpet and swimming laps are some of the many ways of causing eye pressure spikes.”

Increasing population has forced humans to once again step into the domain of animals.

The FDA has issued two warning letters to Bayer for not submitting proof that the Bayer Women’s Low Dose Aspirin + Calcium and Bayer Aspirin With Health Advantage are useful in fighting heart disease and osteoporosis in women.

"These are not FDA-approved products," agency spokeswoman Rita Chappelle said. "They are selling products that are illegal."

The FDA has given a warning to Bayer to remove the medicines from the shelves or else face legal action.

But Bayer defended the medications and its right to market them.

"We stand behind both products and all marketing claims made in their support," the German drugmaker said in a statement.

A research by Rudolph Tanzi of Massachusetts General Hospital and his team have found four more genes that affect the risk of Alzheimer’s disease.

Tanzi's team analyzed samples from more than 1,300 families to come to a conclusion. They also feel that the latest study would help in finding better treatment for the disease.  "We are on the cusp of a rare 'science moment' that could alter the way we diagnose, treat and prevent Alzheimer's disease," said Rudolph Tanzi.